In an ICC dispute, CRA was retained by respondent to assess the damages due to the termination of a distribution agreement for pharmaceuticals in Turkey. CRA analyzed the Turkish market, including pricing and reimbursement issues, to determine the profits lost as a result of the early termination of the distribution agreement
Investment treaty disputes in the life sciences industry
In its global scale and economic impact, the life sciences industry presents unique considerations for investment treaty arbitrations. Recently, the COVID-19...